ISSN 1671-5411 CN 11-5329/R
Volume 18 Issue 6
Jun.  2021
Turn off MathJax
Article Contents
Please cite this article as: Tzoumas A, Kokkinidis DG, Giannopoulos S, Giannakoulas G, Palaiodimos L, Avgerinos DV, Kampaktsis PN, Faillace RT. Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management. J Geriatr Cardiol 2021; 18(6): 479−486. DOI: 10.11909/j.issn.1671-5411.2021.06.002
Citation: Please cite this article as: Tzoumas A, Kokkinidis DG, Giannopoulos S, Giannakoulas G, Palaiodimos L, Avgerinos DV, Kampaktsis PN, Faillace RT. Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management. J Geriatr Cardiol 2021; 18(6): 479−486. DOI: 10.11909/j.issn.1671-5411.2021.06.002

Frailty in patients undergoing transcatheter aortic valve replacement: from risk scores to frailty-based management

doi: 10.11909/j.issn.1671-5411.2021.06.002
More Information
  • loading
  • [1]
    Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005−1011. doi: 10.1016/S0140-6736(06)69208-8
    [2]
    Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013; 62: 1002−1012. doi: 10.1016/j.jacc.2013.05.015
    [3]
    Hinterbuchner L, Strohmer B, Hammerer M, et al. Frailty scoring in transcatheter aortic valve replacement patients. Eur J Cardiovasc Nurs 2016; 15: 384−397. doi: 10.1177/1474515115596640
    [4]
    Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187−2198. doi: 10.1056/NEJMoa1103510
    [5]
    Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686−1695. doi: 10.1056/NEJMoa1200384
    [6]
    Arangalage D, Cimadevilla C, Alkhoder S, et al. Agreement between the new EuroSCORE II, the Logistic EuroSCORE and the Society of Thoracic Surgeons score: implications for transcatheter aortic valve implantation. Arch Cardiovasc Dis 2014; 107: 353−360. doi: 10.1016/j.acvd.2014.05.002
    [7]
    Watanabe Y, Hayashida K, Lefèvre T, et al. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation? Catheter Cardiovasc Interv 2013; 81: 1053−1060. doi: 10.1002/ccd.24702
    [8]
    Durand E, Borz B, Godin M, et al. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013; 111: 891−897. doi: 10.1016/j.amjcard.2012.11.056
    [9]
    Piankova P, Afilalo J. Prevalence and prognostic implications of frailty in transcatheter aortic valve replacement. Cardiol Clin 2020; 38: 75−87. doi: 10.1016/j.ccl.2019.09.011
    [10]
    Afilalo J, Lauck S, Kim DH, et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 2017; 70: 689−700. doi: 10.1016/j.jacc.2017.06.024
    [11]
    Rogers T, Alraies MC, Moussa Pacha H, et al. Clinical frailty as an outcome predictor after transcatheter aortic valve implantation. Am J Cardiol 2018; 121: 850−855. doi: 10.1016/j.amjcard.2017.12.035
    [12]
    Chen MA. Frailty and cardiovascular disease: potential role of gait speed in surgical risk stratification in older adults. J Geriatr Cardiol 2015; 12: 44−56. doi: 10.11909/j.issn.1671-5411.2015.01.006
    [13]
    Thongprayoon C, Cheungpasitporn W, Kashani K. The impact of frailty on mortality after transcatheter aortic valve replacement. Ann Transl Med 2017; 5: 144. doi: 10.21037/atm.2017.01.35
    [14]
    Leng S, Chaves P, Koenig K, et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002; 50: 1268−1271. doi: 10.1046/j.1532-5415.2002.50315.x
    [15]
    Ha FJ, Bissland K, Mandrawa C, et al. Frailty in patients with aortic stenosis awaiting intervention. Intern Med J 2021; 51: 319−326. doi: 10.1111/imj.14737
    [16]
    Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010; 121: 151−156. doi: 10.1161/CIRCULATIONAHA.109.894170
    [17]
    Kampaktsis PN, Kokkinidis DG, Wong SC, et al. The role and clinical implications of diastolic dysfunction in aortic stenosis. Heart 2017; 103: 1481−1487. doi: 10.1136/heartjnl-2017-311506
    [18]
    Papanastasiou CA, Kokkinidis DG, Kampaktsis PN, et al. The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis. JACC Cardiovasc Imaging 2020; 13: 385−392. doi: 10.1016/j.jcmg.2019.03.029
    [19]
    Papanastasiou CA, Kokkinidis DG, Jonnalagadda AK, et al. Meta-analysis of transthoracic echocardiography versus cardiac magnetic resonance for the assessment of aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol 2019; 124: 1246−1251. doi: 10.1016/j.amjcard.2019.07.036
    [20]
    Mamane S, Mullie L, Lok Ok Choo W, et al. Sarcopenia in older adults undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 2019; 74: 3178−3180. doi: 10.1016/j.jacc.2019.10.030
    [21]
    Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489−495. doi: 10.1503/cmaj.050051
    [22]
    Shimura T, Yamamoto M, Kano S, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation 2017; 135: 2013−2024. doi: 10.1161/CIRCULATIONAHA.116.025630
    [23]
    Schoenenberger AW, Moser A, Bertschi D, et al. Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores. JACC Cardiovasc Interv 2018; 11: 395−403. doi: 10.1016/j.jcin.2017.11.012
    [24]
    van Mourik MS, Velu JF, Lanting VR, et al. Preoperative frailty parameters as predictors for outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Neth Heart J 2020; 28: 280−292. doi: 10.1007/s12471-020-01379-0
    [25]
    Anand A, Harley C, Visvanathan A, et al. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 2017; 3: 123−132. doi: 10.1093/ehjqcco/qcw030
    [26]
    Tang L, Sorajja P, Mooney M, et al. Transcatheter aortic valve replacement in patients with severe comorbidities: a retrospective cohort study. Catheter Cardiovasc Interv 2021; 97: E253−E262. doi: 10.1002/ccd.29063
    [27]
    Steinvil A, Buchanan KD, Kiramijyan S, et al. Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement. Am Heart J 2018; 200: 11−16. doi: 10.1016/j.ahj.2018.01.007
    [28]
    Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012; 5: 489−496. doi: 10.1016/j.jcin.2012.02.012
    [29]
    Hermiller JB Jr, Yakubov SJ, Reardon MJ, et al. Predicting early and late mortality after transcatheter aortic valve replacement. J Am Coll Cardiol 2016; 68: 343−352. doi: 10.1016/j.jacc.2016.04.057
    [30]
    Green P, Arnold SV, Cohen DJ, et al. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). Am J Cardiol 2015; 116: 264−269. doi: 10.1016/j.amjcard.2015.03.061
    [31]
    Arnold SV, Spertus JA, Vemulapalli S, et al. Quality-of-life outcomes after transcatheter aortic valve replacement in an unselected population: a report from the STS/ACC Transcatheter Valve Therapy Registry. JAMA Cardiol 2017; 2: 409−416. doi: 10.1001/jamacardio.2016.5302
    [32]
    Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013; 145: 6−23. doi: 10.1016/j.jtcvs.2012.09.002
    [33]
    Yamamoto M, Shimura T, Kano S, et al. Prognostic value of hypoalbuminemia after transcatheter aortic valve implantation (from the Japanese Multicenter OCEAN-TAVI Registry). Am J Cardiol 2017; 119: 770−777. doi: 10.1016/j.amjcard.2016.11.019
    [34]
    Puls M, Sobisiak B, Bleckmann A, et al. Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz Index of activities of daily living. EuroIntervention 2014; 10: 609−619. doi: 10.4244/EIJY14M08_03
    [35]
    Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv 2012; 5: 974−981. doi: 10.1016/j.jcin.2012.06.011
    [36]
    Honda Y, Yamawaki M, Shigemitsu S, et al. Prognostic value of objective nutritional status after transcatheter aortic valve replacement. J Cardiol 2019; 73: 401−407. doi: 10.1016/j.jjcc.2018.11.013
    [37]
    Nemec U, Heidinger B, Sokas C, et al. Diagnosing sarcopenia on thoracic computed tomography: quantitative assessment of skeletal muscle mass in patients undergoing transcatheter aortic valve replacement. Acad Radiol 2017; 24: 1154−1161. doi: 10.1016/j.acra.2017.02.008
    [38]
    Ng TP, Feng L, Nyunt MS, et al. Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med 2015; 128: 1225−1236. doi: 10.1016/j.amjmed.2015.06.017
    [39]
    Verghese J, Mahoney J, Ambrose AF, et al. Effect of cognitive remediation on gait in sedentary seniors. J Gerontol A Biol Sci Med Sci 2010; 65: 1338−1343. doi: 10.1093/gerona/glq127
    [40]
    Binder EF, Schechtman KB, Ehsani AA, et al. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc 2002; 50: 1921−1928. doi: 10.1046/j.1532-5415.2002.50601.x
    [41]
    Cesari M, Vellas B, Hsu FC, et al. A physical activity intervention to treat the frailty syndrome in older persons-results from the LIFE-P study. J Gerontol A Biol Sci Med Sci 2015; 70: 216−222. doi: 10.1093/gerona/glu099
    [42]
    Giné-Garriga M, Guerra M, Pagès E, et al. The effect of functional circuit training on physical frailty in frail older adults: a randomized controlled trial. J Aging Phys Act 2010; 18: 401−424. doi: 10.1123/japa.18.4.401
    [43]
    Gariballa S, Forster S. Dietary supplementation and quality of life of older patients: a randomized, double-blind, placebo-controlled trial. J Am Geriatr Soc 2007; 55: 2030−2034. doi: 10.1111/j.1532-5415.2007.01435.x
    [44]
    Pedersen JL, Pedersen PU, Damsgaard EM. Early nutritional follow-up after discharge prevents deterioration of ADL functions in malnourished, independent, geriatric patients who live alone: a randomized clinical trial. J Nutr Health Aging 2016; 20: 845−853. doi: 10.1007/s12603-015-0629-2
    [45]
    Cameron ID, Fairhall N, Langron C, et al. A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial. BMC Med 2013; 11: 65. doi: 10.1186/1741-7015-11-65
    [46]
    Bibas L, Levi M, Bendayan M, et al. Therapeutic interventions for frail elderly patients: part I. Published randomized trials. Prog Cardiovasc Dis 2014; 57: 134−143. doi: 10.1016/j.pcad.2014.07.004
    [47]
    Gill TM, Baker DI, Gottschalk M, et al. A program to prevent functional decline in physically frail, elderly persons who live at home. N Engl J Med 2002; 347: 1068−1074. doi: 10.1056/NEJMoa020423
    [48]
    Kokkinidis DG, Armstrong EJ, Giri J. Balancing weight loss and sarcopenia in elderly patients with peripheral artery disease. J Am Heart Assoc 2019; 8: e013200. doi: 10.1161/JAHA.119.013200
    [49]
    Ribeiro GS, Melo RD, Deresz LF, et al. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: systematic review and meta-analysis. Eur J Prev Cardiol 2017; 24: 688−697. doi: 10.1177/2047487316686442
    [50]
    Eichler S, Salzwedel A, Reibis R, et al. Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation: predictors of functional and psychocognitive recovery. Eur J Prev Cardiol 2017; 24: 257−264. doi: 10.1177/2047487316679527
    [51]
    Völler H, Salzwedel A, Nitardy A, et al. Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation. Eur J Prev Cardiol 2015; 22: 568−574. doi: 10.1177/2047487314526072
    [52]
    Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49: M85−M94. doi: 10.1093/geronj/49.2.M85
    [53]
    Puri R, Iung B, Cohen DJ, et al. TAVI or no TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J 2016; 37: 2217−2225. doi: 10.1093/eurheartj/ehv756
    [54]
    Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e1159−e1195. doi: 10.1161/CIR.0000000000000503
    [55]
    Otto CM, Kumbhani DJ, Alexander KP, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2017; 69: 1313−1346. doi: 10.1016/j.jacc.2016.12.006
    [56]
    Asgar AW, Ouzounian M, Adams C, et al. 2019 Canadian cardiovascular society position statement for transcatheter aortic valve implantation. Can J Cardiol 2019; 35: 1437−1448. doi: 10.1016/j.cjca.2019.08.011
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (552) PDF downloads(58) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return